Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Gene Therapy

• Publication date

  1999-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.gt.3300989PMID 10516713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High Level Gene Expression in Fibrosarcoma Use of the Stress-inducible grp 78 / BiP Promoter in Targeting

  2006cited by this paper
• Androgen Receptor Activation in Prostatic Tumor Cell Lines by Insulin-like Growth Factor-I, Keratinocyte Growth Factor, and Epidermal Growth Factor1

  2006cited by this paper
• Human amnion membrane matrix as a substratum for axonal regeneration in the central nervous system

  2004cited by this paper
• Properties of PC12 pheochromocytoma cells transplanted to the adult rat brain

  2004cited by this paper
• Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

  1999cited by this paper
• Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging.

  1998cited by this paper
• "Tet-on": a gene switch for the exogenous regulation of transgene expression.

  1998cited by this paper
• “Tet-on”: A Gene Switch for the Exogenous Regulation of Transgene Expression

  1998cited by this paper
• Amelioration of ischaemia‐induced neuronal death in the rat striatum by NGF‐secreting neural stem cells

  1998cited by this paper
• Dose-Dependent Doxycycline-Mediated Adrenocorticotropic Hormone Secretion from Encapsulated Tet-On Proopiomelanocortin Neuro2A Cells in the Subarachnoid Space

  1998cited by this paper
• Human Fetal Astrocytes as an Ex Vivo Gene Therapy Vehicle for Delivering Biologically Active Nerve Growth Factor

  1997cited by this paper
• Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.

  1997cited by this paper
• Selective cell ablation in transgenic mice expressing E. coli nitroreductase

  1997cited by this paper
• Gene transfer to the central nervous system by transplantation of cerebral endothelial cells

  1997cited by this paper
• Promoter attenuation in gene therapy: causes and remedies.

  1997cited by this paper
• Pharmacologic control of a humanized gene therapy system implanted into nude mice.

  1997cited by this paper
• Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts

  1997cited by this paper
• Promoter Attenuation in Gene Therapy: Interferon-γ and Tumor Necrosis Factor-α Inhibit Transgene Expression

  1997cited by this paper
• Progress in Transcriptionally Targeted and Regulatable Vectors for Genetic Therapy

  1997cited by this paper
• Modulation of Erythropoietin Delivery from Engineered Muscles in Mice

  1997cited by this paper
• Advantages of Non-Human Adenoviruses Versus Human Adenoviruses Promoter Attenuation in Gene Therapy: Causes and Remedies

  1997cited by this paper
• Effects of Intraventricular Encapsulated Hngf-Secreting Fibroblasts in Aged Rats

  1996cited by this paper
• Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats.

  1996cited by this paper
• Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences.

  1996cited by this paper
• Chromaffin cell survival from both young and old donors is enhanced by co-grafts of polymer-encapsulated human NGF-secreting cells.

  1996cited by this paper
• Ecdysone-inducible gene expression in mammalian cells and transgenic mice.

  1996cited by this paper
• Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor gene transfer to the rat basal forebrain.

  1996cited by this paper
• Inducible retroviral vectors regulated by lac repressor in mammalian cells.

  1996cited by this paper
• Effects of intraventricular transplantation of NGF‐secreting cells on cholinergic basal forebrain neurons after partial immunolesion

  1996cited by this paper
• In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16.

  1996cited by this paper
• Treatment with genetically engineered fibroblasts producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat

  1996cited by this paper
• The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy.

  1996cited by this paper
• A humanized system for pharmacologic control of gene expression

  1996cited by this paper
• Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts.

  1996cited by this paper
• Regulation of Endothelial Nitric-oxide Synthase during Hypoxia*

  1996cited by this paper
• Ex Vivo Gene Transfer of Brain‐derived Neurotrophic Factor to the Intact Rat Forebrain: Neurotrophic Effects on Cholinergic Neurons

  1996cited by this paper
• Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells

  1996cited by this paper
• Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury.

  1996cited by this paper
• Grafts of Fibroblasts Genetically Modified to Secrete Ngf, Bdnf, Nt-3, or Basic Fgf Elicit Differential Responses in the Adult Spinal Cord

  1996cited by this paper
• Grafts of fibroblasts genetically modified to secrete NGF, BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal cord.

  1996cited by this paper
• Generation of estrogen receptor mutants with altered ligand specificity for use in establishing a regulatable gene expression system.

  1996cited by this paper
• Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain.

  1995cited by this paper
• Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.

  1995cited by this paper
• Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat.

  1995cited by this paper
• Transcriptional Regulatory Sequences of Carcinoembryonic Antigen: Identification and Use with Cytosine Deaminase for Tumor-Specific Gene Therapy

  1995cited by this paper
• Treatment of amyotrophic lateral sclerosis using a gene therapy approach.

  1995cited by this paper
• Gene transfer through the blood–nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis

  1995cited by this paper
• Use of the stress-inducible grp78/BiP promoter in targeting high level gene expression in fibrosarcoma in vivo.

  1995cited by this paper
• Enhanced survival and neuronal differentiation of adrenal chromaffin cells cografted into the striatum with NGF-producing fibroblasts

  1995cited by this paper
• CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: complete rescue of axotomized cholinergic neurons after transplantation into the septum

  1995cited by this paper
• Effects of modulators of tyrosinase activity on expression of murine interleukin-2 cDNA driven by the tyrosinase promoter

  1995cited by this paper
• Polymer-encapsulated Schwannoma cells expressing human nerve growth factor promote the survival of cholinergic neurons after a fimbria-fornix transection.

  1995cited by this paper
• Spatial and temporal control of gene therapy using ionizing radiation

  1995cited by this paper
• Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells.

  1995cited by this paper
• Transcriptional activation by tetracyclines in mammalian cells.

  1995cited by this paper
• Ciliary neurotrophic factor promotes the terminal differentiation of v-myc immortalized sympathoadrenal progenitor cells in vivo.

  1995cited by this paper
• Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells (*)

  1995cited by this paper
• DELIVERY OF NEUROTROPHIC FACTORS TO THE CNS USING ENCAPSULATED CELLS: DEVELOPING TREATMENTS FOR NEURODEGENERATIVE DISEASES.

  1995cited by this paper
• Herpes Simplex Virus Type 1 Amplicon Vectors with Glucocorticoid-Inducible Gene Expression

  1995cited by this paper
• Adrenal chromaffin cells transdifferentiate in response to basic fibroblast growth factor and show directed outgrowth to a nerve growth factor source in vivo.

  1995cited by this paper
• Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis.

  1995cited by this paper
• Axonal regeneration and limited functional recovery following hippocampal deafferentation

  1995cited by this paper
• Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice.

  1995cited by this paper
• Delivery of Neurotrophic Factors to the CNS Using Encapsulated Cells: Developing Treatments for Neurodegenerative Diseases

  1995cited by this paper
• Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo.

  1994cited by this paper
• Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum.

  1994cited by this paper
• Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo

  1994cited by this paper
• A regulatory system for use in gene transfer.

  1994cited by this paper
• Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease.

  1994cited by this paper
• Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

  1994cited by this paper
• Nervous system modification by transplants and gene transfer

  1994cited by this paper
• Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector.

  1994cited by this paper
• Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF).

  1994cited by this paper
• Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons.

  1994cited by this paper
• Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats.

  1993cited by this paper
• A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins.

  1993cited by this paper
• Polymers, Encapsulation, and Artifical Organs (Report on Session 26.0)

  1993cited by this paper
• Polymers, encapsulation, and artificial organs (report on session 26.0). Washington D.C., July 15, 1992.

  1993cited by this paper
• Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age‐related neurodegeneration

  1993cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper
• Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats

  1992cited by this paper
• Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF.

  1992cited by this paper
• Reactive astrocytes are substrates for the growth of adult CNS axons in the presence of elevated levels of nerve growth factor.

  1991cited by this paper
• Genetically modified cells: applications for intracerebral grafting.

  1991cited by this paper
• Grafting of perfused adrenal medullary tissue into the caudate nucleus of patients with Parkinson's disease. Clinica Puerta de Hierro Neural Transplantation Group.

  1991cited by this paper
• Survival and differentiation within the adult mouse striatum of grafted rat pheochromocytoma cells (PC12) genetically modified to express recombinant beta-NGF.

  1991cited by this paper
• Effects of sciatic nerve transplants after fimbria-fornix lesion: examination of the role of nerve growth factor.

  1991cited by this paper
• Survival and differentiation within the adult mouse striatum of grafted rat pheochromocytoma cells (PC12) genetically modified to express recombinant β-NGF

  1991cited by this paper
• Long-term evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation alone.

  1990cited by this paper
• Long-term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway.

  1990cited by this paper
• Gene therapy in the CNS: intracerebral grafting of genetically modified cells.

  1990cited by this paper
• Genetically altered and defined cell lines for transplantation in animal models of Parkinson's disease.

  1990cited by this paper
• Effect of nerve growth factor in adrenal autografts in parkinsonism

  1990cited by this paper
• NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells.

  1990cited by this paper
• Grafting genetically modified cells to the brain: conceptual and technical issues.

  1990cited by this paper
• Autocrine differentiation of PC12 cells mediated by retroviral vectors.

  1990cited by this paper
• Adrenal medulla transplantation into the putamen in Parkinson's disease.

  1990cited by this paper
• Chapter 2 Genetically altered and defined cell lines for transplantation in animal models of Parkinson's disease

  1990cited by this paper
• Trophic factors and neuronal survival.

  1989cited by this paper
• Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up.

  1989cited by this paper

• Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases

  2021cites this paper
• The Strategies of Nanomaterials for Therapy

  2019cites this paper
• Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.

  2017cites this paper
• United States Patent ( 10 ) Patent No . : US 7 , 840 , 263 B 2

  2017cites this paper
• Beneficial effect of diosgenin as a stimulator of NGF on the brain with neuronal damage induced by Aβ-42 accumulation and neurotoxicant injection

  2016cites this paper
• Modulations du métabolisme et de l’autophagie induites par l’exercice physique dans un modèle souris de sclérose latérale amyotrophique (SLA)

  2015cites this paper
• Flavonoids isolated from Lespedeza cuneata G. Don and their inhibitory effects on nitric oxide production in lipopolysaccharide-stimulated BV-2 microglia cells

  2015cites this paper
• Significance of metallothioneins in aging brain.

  2014cites this paper
• Caffeic acid phenethyl ester (CAPE) protects PC12 cells from MPP+ toxicity by inducing the expression of neuron-typical proteins.

  2014cites this paper
• Unrestricted somatic stem cells as vehicle for nerve growth factor gene transfer

  2013cites this paper
• Biomarkers in Parkinson's disease (recent update).

  2013cites this paper
• Leprosy patients: neurotrophic factors and axonal markers in skin lesions.

  2012cites this paper
• Withanolides from the rhizomes of Dioscorea japonica and their cytotoxicity.

  2011cites this paper
• Furostanol saponins from the rhizomes of Dioscorea japonica and their effects on NGF induction.

  2011cites this paper
• Manipulations of metallothionein gene dose accelerate the response to Listeria monocytogenes.

  2009cites this paper
• Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles

  2009cites this paper
• The multi-herbal medicine Gongjin-dan enhances memory and learning tasks via NGF regulation.

  2009cites this paper
• Magnetic nanoparticles control neural stem cell behavior in normal and ischemic brain

  2008cites this paper
• 21 – NGF-producing Cell Transplants for Alzheimer's Disease

  2007cites this paper
• Gene Therapy to the Nervous System

  2006cites this paper
• Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?

  2006cites this paper
• Nerve growth factor in treatment and pathogenesis of Alzheimer's disease.

  2006cites this paper
• Neurons derived from PC12 cells have the potential to develop synapses with primary neurons from rat cortex.

  2006cites this paper
• Gene therapy in Parkinson’s disease

  2004cites this paper
• Exogenous expression of interferon-beta in cultured brain microvessel endothelial cells.

  2004cites this paper
• Systems for regulated or tissue-specific gene expression.

  2004cites this paper
• [Nerve growth factor in neurodegeneration and neurorestorative therapy].

  2004cites this paper
• Gene transfer in experimental medicine.

  2003cites this paper
• Gene Therapy: A Primer for Neurosurgeons

  2003cites this paper
• Herpes Simplex Viruses

  2003cites this paper
• Gene therapy for psychiatric disorders.

  2003cites this paper
• Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.

  2002cites this paper
• Long Term Neurite Outgrowth Enhancing Effect and Neurite Regeneration Effect of an Active Substance from a Brown Alga Sargassum Macrocarpum on Rat Pheochromocytoma PC12D Cells

  2002cites this paper
• Artificial mammalian gene regulation networks-novel approaches for gene therapy and bioengineering.

  2002cites this paper
• PRODUCTION AND PURIFICATION OF HSV-1 VECTORS AND ITS USE FOR GENE TRANSFER TO HUMAN CD34⁺ CELLS

  2002cites this paper
• Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters

  2001cites this paper
• Efficient in vitro and in vivo gene regulation of a retrovirally delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter

  2001cites this paper
• Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease.

  2001cites this paper
• [Cellular mechanisms of neuroplasticity].

  2000cites this paper